The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Fluoro-4-(4-methyl-5-(4-(piperazin-1-yl)phenyl)pyridin-3-yl)benzamide ID: ALA4571351
PubChem CID: 155562760
Max Phase: Preclinical
Molecular Formula: C23H23FN4O
Molecular Weight: 390.46
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(-c2ccc(N3CCNCC3)cc2)cncc1-c1ccc(C(N)=O)c(F)c1
Standard InChI: InChI=1S/C23H23FN4O/c1-15-20(16-2-5-18(6-3-16)28-10-8-26-9-11-28)13-27-14-21(15)17-4-7-19(23(25)29)22(24)12-17/h2-7,12-14,26H,8-11H2,1H3,(H2,25,29)
Standard InChI Key: SLVUSGRZIHABCV-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
19.3058 -4.3831 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3046 -5.2067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0127 -5.6157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7264 -5.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7236 -4.3795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0109 -3.9701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0185 -6.4349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3049 -6.8468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3044 -7.6674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0125 -8.0769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7268 -7.6641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7238 -6.8449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0211 -8.8956 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3079 -9.3079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3069 -10.1256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0173 -10.5373 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7264 -10.1291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7291 -9.3052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4389 -5.6138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4309 -3.9654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1445 -4.3771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1334 -2.7345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4265 -3.1474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8517 -3.1403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8546 -3.9603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5567 -2.7271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2671 -3.1310 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.5514 -1.9099 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.1274 -1.9173 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
13 14 1 0
13 18 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
10 13 1 0
4 19 1 0
20 21 2 0
21 25 1 0
24 22 1 0
22 23 2 0
23 20 1 0
5 20 1 0
24 25 2 0
24 26 1 0
26 27 1 0
26 28 2 0
22 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 390.46Molecular Weight (Monoisotopic): 390.1856AlogP: 3.37#Rotatable Bonds: 4Polar Surface Area: 71.25Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.67CX Basic pKa: 8.88CX LogP: 3.13CX LogD: 1.64Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.72Np Likeness Score: -0.94
References 1. Ensan D, Smil D, Zepeda-Velázquez CA, Panagopoulos D, Wong JF, Williams EP, Adamson R, Bullock AN, Kiyota T, Aman A, Roberts OG, Edwards AM, O'Meara JA, Isaac MB, Al-Awar R.. (2020) Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma., 63 (9): [PMID:32369358 ] [10.1021/acs.jmedchem.0c00395 ]